Count | |
14 | |
1 | |
3 | |
2 | |
4 | |
Antilipemic Agents/*administration & dosage/pharmacology/therapeutic use | 1 |
Antilipemic Agents/administration & dosage/pharmacokinetics/*pharmacology | 1 |
1 | |
1 | |
1 | |
2 | |
1 | |
75 | |
1 | |
37 | |
1 | |
14 | |
29 | |
4 | |
1 | |
1 | |
2 | |
1 | |
1 | |
1 | |
5 | |
1 | |
7 | |
1 | |
1 | |
1 | |
4 | |
1 | |
1 | |
1 | |
Antilipemic Agents/pharmacokinetics/*pharmacology/*therapeutic use | 1 |
1 | |
Antilipemic Agents/blood/chemistry/*metabolism/pharmacokinetics | 1 |
Antilipemic Agents/*chemical synthesis/chemistry/pharmacology | 1 |
Antilipemic Agents/adverse effects/metabolism/pharmacokinetics | 1 |
Antilipemic Agents/*chemical synthesis/pharmacokinetics/pharmacology | 1 |
Antilipemic Agents/adverse effects/*pharmacokinetics/therapeutic use | 1 |
1 | |
11 | |
1 | |
1 | |
9 | |
3 | |
6 | |
3 | |
1 | |
2 | |
1 | |
5 | |
30 | |
1 | |
2 | |
17 | |
10 | |
6 | |
2 | |
2 | |
2 | |
1 | |
9 | |
10 | |
2 | |
12 | |
6 | |
1 | |
1 | |
2 | |
26 | |
10 | |
1 | |
4 | |
2 | |
66 | |
2 | |
2 | |
29 | |
3 | |
2 | |
1 | |
1 | |
1 | |
2 | |
3 | |
6 | |
1 | |
1 | |
1 | |
11 | |
4 | |
5 | |
1 | |
7 | |
6 | |
1 | |
58 | |